P.2.e.018 Management of side effects associated with new treatments for depressive symptoms in bipolar disorder

✍ Scribed by J.R. Calabrese; R.M.A. Hirschfeld; K.D. Wagner

Book ID: 118592835
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 16
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(06)70413-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.e.019 Specificity of effect of queti

P.2.e.019 Specificity of effect of quetiapine for depressive symptoms in bipolar disorder

✍ R.M.A. Hirschfeld; J.R. Calabrese 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 69 KB

P.2.c.018 Safety of quetiapine for treat

P.2.c.018 Safety of quetiapine for treatment of insomnia in patients with major depressive disorder

✍ S. Lee; J.H. Han; S.C. Hong; J.H. Jeong; H.J. Seo; H.K. Lim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

P.2.g.003 Aripiprazole for the treatment

P.2.g.003 Aripiprazole for the treatment of involuntary movement symptoms in patients with major depressive disorder

✍ A.R. Cho; W.S. Kang; S.M. Lee; M.H. Hong; J.K. Park 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.2.e.006 Prophylactic effect of lithium

P.2.e.006 Prophylactic effect of lithium in maintenance treatment of bipolar disorder is associated with plasma levels >0.6 mEq/L

✍ W.A. Nolen; B. Paulsson; R.H. Weisler 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 199 KB

P.2.e.024 Bipolar I or II disorder patie

P.2.e.024 Bipolar I or II disorder patients in the course of a major depressive episode improve significantly with atypical antipsychotic treatment

✍ D. Souéry; K. Audenaert; A. Vankeirsbilck; T. Vanlerberghe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB